Media Center

• Today, @AmerGeriatrics released a new clinical framework to guide safe and patient-centered prescribing of obesity medications in older adults in @AGSJournal. Read more at: https://doi.org/10.1111/jgs.70769 

New York, NY (October 29, 2026) – Today, the American Geriatrics Society (AGS) released a new framework to assist clinicians to safely prescribe obesity medications in older adults. 

Organized around a series of cases, the framework offers a practical approach to prescribing obesity medications, including GLP-1 medications, that act through gut-derived hormonal pathways to older adults. While these medications offer promising benefits for weight management, glycemic control, and other health conditions, older adults are under-represented in clinical trials. The AGS framework emphasizes that clinicians should carefully consider age-related factors such as sarcopenia and frailty, risk of lean muscle loss, malnutrition, and dehydration.

This new paper, developed by the AGS Healthy Aging Special Interest Group, discusses key considerations for the use of obesity medications in older adults. The paper explores how to apply the Geriatrics 5Ms Framework (Mind, Mobility, Medications, Multicomplexity, and Matters Most) to incretin therapy in older adults. 

• Today, @AmerGeriatrics released their findings from the AGS Older Adults Vaccine Initiative in @AGSJournal. Read more at: https://doi.org/10.1111/jgs.70770

New York, NY (October 28, 2026) – Today, the American Geriatrics Society (AGS) released a paper in the Journal of the American Geriatrics Society detailing findings from the AGS Older Adults Vaccine (AGS OAV) Initiative (https://doi.org/10.1111/jgs.70770).  

The American Geriatrics Society launched the Older Adults Vaccine Initiative (AGS OAV Initiative) in 2021, with support from the Centers for Disease Control and Prevention (CDC) of the U.S. Department of Health and Human Services (HHS) under a five-year financial assistance award to the Council of Medical Specialty Societies (CMSS) called Specialty Societies Advancing Older Adult Immunization (SSAAI). 

• Today, @AmerGeriatrics released a new position statement on generative AI in the care of older adults in @AGSJournal. Read more at: https://doi.org/10.1111/jgs.70566

New York, NY (July 21, 2026) – Today, the American Geriatrics Society (AGS) released a first of its kind position statement on generative AI (GenAI) in the care of older adults.

It is the first geriatrics-focused framework to address the ethical, clinical, and systems-level implications of GenAI in the care of older adults, translating foundational geriatrics principles into actionable guidance for clinical use, health system governance, and technology development. AGS established a writing group to develop this new position paper to ensure that the adoption of AI improves person-centered, equitable, and age-friendly care, rather than undermining it. 

The new statement includes recommendations on the ethical use of AI, clinical integration and oversight, transparency and documentation, privacy protections, and governance across the AI lifecycle. It is essential to note that GenAI does not replace clinical judgment and relational care and must be integrated with care for responsible use in the care of older adults. 

• Today, @AmerGeriatrics released an updated position statement on advancing healthcare of LGBTQI+ Older Adults in @AGSJournal. Read more: https://doi.org/10.1111/jgs.70470

New York, NY (June 16, 2026) – Today, the American Geriatrics Society (AGS) released an updated position statement on advancing the healthcare of lesbian, bisexual, transgender, queer, intersex and more (LGBTQI+) older adults. In an effort to support progress on eliminating discrimination against LGBTQI+ older adults in healthcare and supporting integration of evidence-based approaches to caring for these older adults across care settings, AGS established a writing group to update and build upon the 2015 position statement.

The updated position statement includes recommendations on inclusive education, policy reform, and focused research such as standardized training for all healthcare staff, with specialized instruction for clinicians caring for LGBTQI+ older adults; maintaining nondiscriminatory measures and supporting chosen families in caregiving in policies; and advancing sexual orientation and gender identity (SOGI) data collection and investigating mechanisms that drive disparities and facilitate health promotion.

• AGS welcomes Alison A. Moore, MD, MPH, FACP, AGSF as its new President at the 2026 Virtual AGS Annual Scientific Meeting (#AGS26) https://bit.ly/48snAi5 

New York (April 27, 2026) — Alison A. Moore, MD, MPH, FACP, AGSF, will begin her term as President of the American Geriatrics Society (AGS) at the upcoming 2026 AGS Virtual Annual Scientific Meeting, taking place April 30 – May 2, 2026 (pre-conference day: April 29). Dr. Moore, a respected clinician-scientist, educator and administrator, has dedicated her career to advancing the health and well-being of older adults, with particular expertise in older adults and the use of alcohol, cannabis, and other substances. Her other clinical interests include technology, health equity, aging, and HIV. She has been an active member of AGS since 1994, serving in numerous leadership roles.